<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39325815</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>28</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>9</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Estimating population infection rates from non-random testing data: Evidence from the COVID-19 pandemic.</ArticleTitle><Pagination><StartPage>e0311001</StartPage><MedlinePgn>e0311001</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0311001</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0311001</ELocationID><Abstract><AbstractText>To effectively respond to an emerging infectious disease outbreak, policymakers need timely and accurate measures of disease prevalence in the general population. This paper presents a new methodology to estimate real-time population infection rates from non-random testing data. The approach compares how the observed positivity rate varies with the size of the tested population and applies this gradient to infer total population infections. Applying this methodology to daily testing data across U.S. states during the first wave of the COVID-19 pandemic, we estimated widespread undiagnosed COVID-19 infections. Nationwide, we found that for every identified case, there were 12 population infections. Our prevalence estimates align with results from seroprevalence surveys, alternate approaches to measuring COVID-19 infections, and total excess mortality during the first wave of the pandemic.</AbstractText><CopyrightInformation>Copyright: © 2024 Benatia et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Benatia</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Applied Economics, HEC Montréal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Godefroy</LastName><ForeName>Raphael</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Economics, Université de Montréal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lewis</LastName><ForeName>Joshua</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-2779-9716</Identifier><AffiliationInfo><Affiliation>Department of Economics, Université de Montréal, Quebec, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016036" MajorTopicYN="N">Seroepidemiologic Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086742" MajorTopicYN="N">COVID-19 Testing</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>26</Day><Hour>19</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>26</Day><Hour>19</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>26</Day><Hour>13</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39325815</ArticleId><ArticleId IdType="pmc">PMC11426536</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0311001</ArticleId><ArticleId IdType="pii">PONE-D-23-40791</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pei S, Kandula S, Shaman J. Differential Effects of Intervention Timing on COVID-19 Spread in the United States. Science Advances. 2020;6(49):eabd6370. doi: 10.1126/sciadv.abd6370</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abd6370</ArticleId><ArticleId IdType="pmc">PMC7821895</ArticleId><ArticleId IdType="pubmed">33158911</ArticleId></ArticleIdList></Reference><Reference><Citation>Markel H, Lipman H, Navarro J, Sloan A, Michalsen J, Stern A, et al.. Nonpharmaceutical Interventions Implemented by US Cities During the 1918-1919 Influenza Pandemic. JAMA. 2007;298(6):644–654. doi: 10.1001/jama.298.6.644</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.298.6.644</ArticleId><ArticleId IdType="pubmed">17684187</ArticleId></ArticleIdList></Reference><Reference><Citation>Bootsma M, Ferguson N. The Effect of Public Health Measures on the 1918 Influenza Pandemic in U.S. Cities. Proceedings of the National Academy of Sciences. 2007;104(8):7588–7593. doi: 10.1073/pnas.0611071104</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0611071104</ArticleId><ArticleId IdType="pmc">PMC1849868</ArticleId><ArticleId IdType="pubmed">17416677</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong Y, Mo X, Hu Y, Qi X, Jiang F, et al.. Epidemiological Characteristics of 2143 Pediatric Patients with 2019 Coronavirus Disease in China. Pediatrics. 2020.</Citation></Reference><Reference><Citation>Pan X, Chen D, Xia Y, Wu X, Li T, et al.. Asymptomatic Cases in a Family Cluster with SARS-CoV-2 Infection. The Lancet Infectious Disease. 2020;20(4):410–411. doi: 10.1016/S1473-3099(20)30114-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30114-6</ArticleId><ArticleId IdType="pmc">PMC7158985</ArticleId><ArticleId IdType="pubmed">32087116</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai Y, Yao L, Wei T, Tian F, Jin D, et al.. Presumed Asymptomatic Carrier Transmission of COVID-19. JAMA. 2020. doi: 10.1001/jama.2020.2565</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.2565</ArticleId><ArticleId IdType="pmc">PMC7042844</ArticleId><ArticleId IdType="pubmed">32083643</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer R, Kissane E, Madrigal A. The COVID Tracking Project. https://covidtracking.com/; 2020.</Citation></Reference><Reference><Citation>Korea CDC. Korea Centers for Disease Control and Prevention. https://www.cdc.go.kr/board/board.es?mid=&amp;bid=0030; 2020.</Citation></Reference><Reference><Citation>Heckman J. The Common Structure of Statistical Models of Truncation, Sample Selection and Limited Dependent Variables and a Simple Estimator for Such Models. Annals of Economics and Social Measurement. 1976;5(4):475–492.</Citation></Reference><Reference><Citation>Heckman J. Sample Selection Bias as a Specification Error. Econometrica. 1979;4(7):153–162. doi: 10.2307/1912352</Citation><ArticleIdList><ArticleId IdType="doi">10.2307/1912352</ArticleId></ArticleIdList></Reference><Reference><Citation>Heckman J, Lalonde R, Smith J. The Economics and Econometrics of Active Labor Market Programs. In: Ashenfelter O, Card D, editors. Handbook of Labor Economics. Amsterdam: North-Holland; 1999. p. 1866–2097.</Citation></Reference><Reference><Citation>Blundell R, Costa Dias M. Evaluation Methods for Non-experimental Data. Fiscal Studies. 2002;21(4):427–468. doi: 10.1111/j.1475-5890.2000.tb00031.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1475-5890.2000.tb00031.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Das M, Newey W, Vella F. Nonparametric Estimation of Sample Selection Models. The Review of Economic Studies. 2003;70(1):33–58. doi: 10.1111/1467-937X.00236</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1467-937X.00236</ArticleId></ArticleIdList></Reference><Reference><Citation>Newey W. Two-Step Series Estimation of Sample Selection Models. Econometrics Journal. 2009;12(S1):S217–S229. doi: 10.1111/j.1368-423X.2008.00263.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1368-423X.2008.00263.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Billah MA, Khan MMMMN. Reproductive number of coronavirus: A systematic review and meta-analysis based on global level evidence. PLOS ONE. 2020;15(1):e0242128. doi: 10.1371/journal.pone.0242128</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0242128</ArticleId><ArticleId IdType="pmc">PMC7657547</ArticleId><ArticleId IdType="pubmed">33175914</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorci GBF, Morand S. Explaining among-country variation in COVID-19 case fatality rate. Scientific Reports. 2020;10:18909. doi: 10.1038/s41598-020-75848-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-75848-2</ArticleId><ArticleId IdType="pmc">PMC7609641</ArticleId><ArticleId IdType="pubmed">33144595</ArticleId></ArticleIdList></Reference><Reference><Citation>Alene M, Yismaw L, Assemie MA, Ketema DB, Mengist B, Kassie B, et al.. Magnitude of asymptomatic COVID-19 cases through the course of infection: A systematic review and meta-analysis. PLOS ONE. 2021;16(3):e0249090. doi: 10.1371/journal.pone.0249090</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0249090</ArticleId><ArticleId IdType="pmc">PMC7987199</ArticleId><ArticleId IdType="pubmed">33755688</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferguson N, Laydon D, Nedjati-Gilani G, Imai N, Ainslie K, Baguelin M, et al. Impacts of Non-pharmaceutical Interventions to Reduce COVID-19 Mortality and Healthcare Demand. London: Imperial College COVID-19 Response Team; 2020.</Citation></Reference><Reference><Citation>Perkins A, Cavany S, Moore S, Oidtman R, Lerch A, Poterek M. Estimating Unobserved SARS-CoV-2 Infections in the United States. Proceedings of the National Academy of Sciences. 2020;117(36):22597–22602. doi: 10.1073/pnas.2005476117</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2005476117</ArticleId><ArticleId IdType="pmc">PMC7486725</ArticleId><ArticleId IdType="pubmed">32826332</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R, Pei S, Chen B, Song Y, Zhang T, Yang W, et al.. Substantial Undocumented Infection Facilitates the Rapid Dissemination of Novel Coronavirus (SARS-Cov2). Science. 2020. doi: 10.1126/science.abb3221</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb3221</ArticleId><ArticleId IdType="pmc">PMC7164387</ArticleId><ArticleId IdType="pubmed">32179701</ArticleId></ArticleIdList></Reference><Reference><Citation>Riou J, Hauser A, Counotte M, Althaus C. Adjusting Age-Specific Case Fatality Rates during the COVID-19 Epidemic in Hubei, China, January and February. medRxiv Working Paper; 2020.</Citation></Reference><Reference><Citation>Johndrow J, Lum K, Ball P. Estimating SARS-CoV-2 Positive Americans using Deaths-only Data. Working Paper; 2020.</Citation></Reference><Reference><Citation>Javan E, Fox S, Meyers L. Probability of Current COVID-19 Outbreaks in All US Counties. Working Paper; 2020.</Citation></Reference><Reference><Citation>Verity R, Okell L, Dorigatti I, Winskill P, Whittaker C, et al.. Estimates of the Severity of Coronavirus Disease 2019: A Model-based Analysis. Lancet Infectious Disease. 2020. doi: 10.1016/S1473-3099(20)30243-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30243-7</ArticleId><ArticleId IdType="pmc">PMC7158570</ArticleId><ArticleId IdType="pubmed">32240634</ArticleId></ArticleIdList></Reference><Reference><Citation>García-García D, Morales E, de la Fuente-Nunez C, Vigo I, Fonfría ES, Bordehore C. Identification of the first COVID-19 infections in the US using a retrospective analysis (REMEDID). Spatial and Spatio-temporal Epidemiology. 2022;42:100517. doi: 10.1016/j.sste.2022.100517</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sste.2022.100517</ArticleId><ArticleId IdType="pmc">PMC9087146</ArticleId><ArticleId IdType="pubmed">35934325</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf; 2020.</Citation></Reference><Reference><Citation>Manski C, Molinari F. Estimating the COVID-19 Infection Rate: Anatomy of an Inference Problem. Journal of Econometrics. 2020;Forthcoming. doi: 10.1016/j.jeconom.2020.04.041</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jeconom.2020.04.041</ArticleId><ArticleId IdType="pmc">PMC7200382</ArticleId><ArticleId IdType="pubmed">32377030</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatfield C. Model Uncertainty, Data Mining, and Statistical Inference. Journal of the Royal Statistics Society. 1995;3:419–444. doi: 10.2307/2983440</Citation><ArticleIdList><ArticleId IdType="doi">10.2307/2983440</ArticleId></ArticleIdList></Reference><Reference><Citation>U S Census Bureau. U.S. Census Bureau, Population Division. Annual Estimates of the Resident Population for the United States, Regions, States, and Puerto Rico: April 1, 2010 to July 1, 2019. Washington, DC; 2019.</Citation></Reference><Reference><Citation>Berry I, Soucy J, Tuite A, Fisman D. Open Access Epidemiological Data and an Interactive Dashboard to Monitor the COVID-19 Outbreak in Canada. CMAJ: 2020. doi: 10.1503/cmaj.75262</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.75262</ArticleId><ArticleId IdType="pmc">PMC7162433</ArticleId><ArticleId IdType="pubmed">32392510</ArticleId></ArticleIdList></Reference><Reference><Citation>Benatia D, Godefroy R, Lewis J. Estimating of COVID-19 Cases across Four Canadian Provinces. Canadian Public Policy. 2020;46(S3):S203–S216. doi: 10.3138/cpp.2020-035</Citation><ArticleIdList><ArticleId IdType="doi">10.3138/cpp.2020-035</ArticleId><ArticleId IdType="pmc">PMC8228716</ArticleId><ArticleId IdType="pubmed">38630004</ArticleId></ArticleIdList></Reference><Reference><Citation>Foster, T and L Fernandez and S Porter and N Pharris-Ciurej. Age, Sex, and Racial/Ethnic Disparities and Temporal-Spatial Variation in Excess All-Cause Mortality During the COVID-19 Pandemic: Evidence from Linked Administrative and Census Bureau Data. U.S. Census Bureau Discussion Paper; 2022.</Citation></Reference><Reference><Citation>Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al.. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus – Infected Pneumonia. New England Journal of Medicine. 2020. doi: 10.1056/NEJMoa2001316</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2001316</ArticleId><ArticleId IdType="pmc">PMC7121484</ArticleId><ArticleId IdType="pubmed">31995857</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauer S, Grantz K, Bi Q, Jones F, Zheng Q, Meredith H, et al.. The Incubation Period of Coronavirus Disease 2019 (COVID-19) from Publicly Reported Confirmed Cases: Estimation and Application. New England Journal of Medicine. 2020. doi: 10.7326/M20-0504</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-0504</ArticleId><ArticleId IdType="pmc">PMC7081172</ArticleId><ArticleId IdType="pubmed">32150748</ArticleId></ArticleIdList></Reference><Reference><Citation>García-García D, Vigo M, Fonfría E, Herrador Z, Navarro M, Bordehore C. Retrospective Methodology to Estimate Daily Infections from Deaths (REMEDID) in COVID-19: the Spain Case Study. Scientific Reports. 2021;11:11274. doi: 10.1038/s41598-021-90051-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-90051-7</ArticleId><ArticleId IdType="pmc">PMC8163852</ArticleId><ArticleId IdType="pubmed">34050198</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchan, L. Coronavirus: Lockdown one week earlier could have halved death toll, says Neil Ferguson. The Independent, https://www.independent.co.uk/news/uk/politics/uk-lockdown-coronavirus-death-toll-neil-ferguson-a9559051.html; 2020.</Citation></Reference><Reference><Citation>Unruh L, Allin S, Marchildon G, Burke S, Barry S, Siersbaek R, et al.. A Comparison of 2020 Health Policy Response to the COVID-19 Pandemic in Canada, Ireland, the United Kingdom and the United States. Health Policy. 2021;126:427–437. doi: 10.1016/j.healthpol.2021.06.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.healthpol.2021.06.012</ArticleId><ArticleId IdType="pmc">PMC9187506</ArticleId><ArticleId IdType="pubmed">34497031</ArticleId></ArticleIdList></Reference><Reference><Citation>Worobey M, Pekar J, Larsen B, Nelson M, Hill V, Joy J, et al.. The Emergence of SARS-CoV-2 in Europe and North America. Science. 2020;370:564–570. doi: 10.1126/science.abc8169</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc8169</ArticleId><ArticleId IdType="pmc">PMC7810038</ArticleId><ArticleId IdType="pubmed">32912998</ArticleId></ArticleIdList></Reference><Reference><Citation>Maurano M, Ramaswami S, Zappile P, Dimartino D, Boytard L, Ribiero-Dos-Santo A, et al.. Sequencing Identifies Multiple Early Introductions of SARS-CoV-2 to the New York Region. Science. 2020;30(12):1781–1788.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7706732</ArticleId><ArticleId IdType="pubmed">33093069</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng X, Gu W, Federman S, du Plessis L, Pybus O, Faria N, et al.. Genomic Surveillance Reveals Multiple Introductions of SARS-CoV-2 into Northern California. Science. 2020;369:582–587. doi: 10.1126/science.abb9263</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb9263</ArticleId><ArticleId IdType="pmc">PMC7286545</ArticleId><ArticleId IdType="pubmed">32513865</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeller M and Gangavarapu K and Anderson C and Smither A and Vanchiere J and Rose R, et al.. Emergence of an Early SARS-CoV-2 Epidemic in the United States. medRxiv; 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8313480</ArticleId><ArticleId IdType="pubmed">34508652</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Xie X, Zhong Z, Zhao W, Zheng C, Wang F. Chest CT for Typical 2019-nCoV Pneumonia: Relationship to Negative RT-PCR Testing. Radiology. 2020. doi: 10.1148/radiol.2020200343</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2020200343</ArticleId><ArticleId IdType="pmc">PMC7233363</ArticleId><ArticleId IdType="pubmed">32049601</ArticleId></ArticleIdList></Reference><Reference><Citation>Ai T, Yang Z, Hou H, Zhan C, Chen C, Lv W, et al.. Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report on 1014 Cases. Radiology. 2020. doi: 10.1148/radiol.2020200642</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2020200642</ArticleId><ArticleId IdType="pmc">PMC7233399</ArticleId><ArticleId IdType="pubmed">32101510</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Yang M, Shen C, Wang F, Yuan J, Li J, et al. Evaluating the Accuracy of Different Respiratory Specimens in the Laboratory Diagnosis and Monitoring the Viral Shedding of 2019-nCoV Infections. medRxiv Working Paper; 2020.</Citation></Reference><Reference><Citation>Wooldridge J. Econometric Analysis of Cross Section and Panel Data. Cambridge, MA: MIT Press; 2002.</Citation></Reference><Reference><Citation>CDC. Centers for Disease Control and Prevention: Coronavirus (COVID-19). https://www.cdc.gov/coronavirus/2019-ncov/index.html; 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">34009769</ArticleId></ArticleIdList></Reference><Reference><Citation>Linton N, Kobayashi T, Yang Y, Hayashi K, Akhmetzhanov A, Jung S, et al.. Incubation Period and Other Epidemiological Characteristics of 2019 Novel Coronavirus Infections with Right Truncation: A Statistical Analysis of Publicly Available Data. Journal of Clinical Medicine. 2020;9(2):538. doi: 10.3390/jcm9020538</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9020538</ArticleId><ArticleId IdType="pmc">PMC7074197</ArticleId><ArticleId IdType="pubmed">32079150</ArticleId></ArticleIdList></Reference><Reference><Citation>Testa, C and N Krieger and J Chen and W Hanage. Visualizing the Lagged Connection Between COVID-19 Cases and Deaths in the United States: An Animation Using Per Capita State-Level Data (January 22, 2020—July 8, 2020. HCPDS Working Paper; 2020. 4.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>